Trade

with

Alimera Sciences Inc
(NASDAQ: ALIM)
AdChoices
4.88
+0.03
+0.62%
After Hours :
4.88
0.00
0.00%

Open

4.79

Previous Close

4.85

Volume (Avg)

223.16k (271.74k)

Day's Range

4.79-4.93

52Wk Range

1.65-8.44

Market Cap.

196.06M

Dividend Rate ( Yield )

-

Beta

1.37

Shares Outstanding

40.42M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • -

    • Net Income

    • -

    • Market Cap.

    • 196.06M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -595.36

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.37

    • Forward P/E

    • -

    • Price/Sales

    • 28.49

    • Price/Book Value

    • -14.53

    • Price/Cash flow

    • -6.04

      • EBITDA

      • -

      • Return on Capital %

      • -82.13

      • Return on Equity %

      • -

      • Return on Assets %

      • -82.13

      • Book Value/Share

      • -0.34

      • Shares Outstanding

      • 40.42M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 1,123.50

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -

          • 7.80

          • Net Income

            Q/Q (last year)

          • -

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • -

          • 6.10

          • Net Income

            5-Year Annual Average

          • -

          • 3.73

          • Dividends

            5-Year Annual Average

          • -

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 53.21

            • 69.92

            • Pre-Tax Margin

            • -594.20

            • 21.84

            • Net Profit Margin

            • -595.36

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.32

              • Current Ratio

              • 11.28

              • 1.92

              • Quick Ratio

              • 10.20

              • 1.31

              • Interest Coverage

              • -

              • 17.64

              • Leverage Ratio

              • -

              • 2.03

              • Book Value/Share

              • -0.34

              • 14.72

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -4.91

                • 21.74

                • P/E Ratio 5-Year High

                • -12.45

                • 193.96

                • P/E Ratio 5-Year Low

                • -1.07

                • 87.26

                • Price/Sales Ratio

                • 29.24

                • 3.68

                • Price/Book Value

                • -14.93

                • 3.66

                • Price/Cash Flow Ratio

                • -6.04

                • 13.76

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -

                    (-)

                  • 17.42

                    (18.66)

                  • Return on Assets %

                    (5-Year Average)

                  • -82.13

                    (-113.60)

                  • 8.45

                    (8.77)

                  • Return on Capital %

                    (5-Year Average)

                  • -

                    (-)

                  • 12.41

                    (13.18)

                  • Income/Employee

                  • -

                  • 90.07k

                  • Inventory Turnover

                  • 1.75

                  • 2.46

                  • Asset Turnover

                  • 0.14

                  • 0.46

                  Current Historical
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  100.78%

                  Mutual Fund Ownership

                  5.23%

                  Float

                  56.01%

                  5% / Insider Ownership

                  0.98%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • iShares Russell 2000 (AU)

                  •  

                    407,885

                  • -1.00

                  • 0.90

                  • Vanguard Total Stock Mkt Idx

                  •  

                    314,082

                  • 5.14

                  • 0.78

                  • Vanguard Extended Market Index Fund

                  •  

                    192,912

                  • 17.53

                  • 0.48

                  • iShares Russell 2000 Growth

                  •  

                    188,597

                  • 0.77

                  • 0.42

                  • Vanguard Instl Total Stock Market Index

                  •  

                    121,750

                  • 0.00

                  • 0.30

                  • Bridgeway Ultra Small Company Market

                  •  

                    121,600

                  • 0.00

                  • 0.30

                  • Highland Long/Short Healthcare Fund

                  •  

                    88,500

                  • -39.28

                  • 0.22

                  • CREF Stock

                  •  

                    73,306

                  • 0.00

                  • 0.18

                  • iShares Micro-Cap

                  •  

                    62,560

                  • 0.00

                  • 0.14

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    47,590

                  • 0.00

                  • 0.12

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Intersouth Partners

                  •  

                    4,877,480

                  • 0.00%

                  • 12.87

                  • Domain Associates, LLC

                  •  

                    3,644,702

                  • -13.00%

                  • 9.61

                  • Palo Alto Investors, LLC

                  •  

                    3,634,984

                  • -50.00%

                  • 9.01

                  • Polaris Venture Management Co IV LLC

                  •  

                    3,148,355

                  • 0.00%

                  • 7.80

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Major

                  Type

                  Distressed

                  Style

                  Small Core

                  Alimera Sciences Inc is a Delaware corporation incorporated on June 4, 2003. The Company together with its subsidiaries is engaged in the research, development and commercialization of prescription ophthalmic pharmaceuticals. Its onl...morey commercial product is ILUVIEN, which has received marketing authorization in Austria, the United Kingdom, Portugal, France, Germany and Spain, and has been recommended for marketing authorization in Italy, for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered insufficiently responsive to available therapies. ILUVIEN is the first product approved for chronic DME in the United Kingdom and European Union. ILUVIEN has not been approved by the U.S. Food and Drug Administration. ILUVIEN is an intravitreal implant providing a t...moreherapeutic effect for up to 36 months in the treatment of vision impairment associated with chronic DME by delivering sustained sub-microgram levels of FAc, a non-proprietary corticosteroid. Intravitreal refers to the space inside the eye behind the lens that contains the jelly-like substance called vitreous. DME is a disease of the retina which affects individuals with diabetes and can lead to severe vision loss and blindness. ILUVIEN is inserted in the back of the patient’s eye in a non-surgical procedure using a sterile preloaded applicator employing a 25-gauge needle, which allows for a self-sealing wound. This procedure is very similar to the administration of an intravitreal injection, a procedure commonly employed by retinal specialists. The majority of its sales have been in Germany. The Company faces competition from pharmaceutical companies, specialty pharmaceutical companies and biotechnology companies. The manufacture and packaging of pharmaceutical products such as ILUVIEN are subject to the requirements of the FDA and similar foreign regulatory entities.lessless

                  Key People

                  Mr. C. Daniel Myers

                  CEO/Director/Founder/President

                  Philip R. Tracy

                  Chairman of the Board/Director

                  Mr. David R. Holland

                  Founder/Senior VP, Divisional

                  Mr. Richard S. Eiswirth, Jr

                  CFO/Chief Accounting Officer/COO/Secretary

                  Mr. Philip Ashman

                  Managing Director, Geographical/Senior VP

                  • Alimera Sciences Inc

                  • 6120 Windward Parkway

                  • Alpharetta, GA 30005

                  • USA.Map

                  • Phone: +1 678 990-5740

                  • Fax: +1 678 990-5744

                  • alimerasciences.com

                  Incorporated

                  2003

                  Employees

                  31

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: